CGP 36742
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


CGP 36742
Description :
CGP 36742 (SGS-742) is an orally active and selective antagonist of GABAB receptor (IC50 = 36 µM) . CGP 36742 is a blood-brain barrier (BBB) penetrant compound and improves cognitive performances. CGP 36742 can be used for depression study[1][2][3][4].Product Name Alternative :
SGS-742UNSPSC :
12352211Hazard Statement :
H302, H319Target :
GABA ReceptorType :
Reference compoundRelated Pathways :
Membrane Transporter/Ion Channel; Neuronal SignalingApplications :
Neuroscience-NeuromodulationField of Research :
Neurological DiseaseAssay Protocol :
https://www.medchemexpress.com/cgp-36742.htmlPurity :
98.0Solubility :
H2O : 125 mg/mL (ultrasonic)Smiles :
O=P(CCCN)(O)CCCCMolecular Formula :
C7H18NO2PMolecular Weight :
179.20Precautions :
H302, H319References & Citations :
[1]Nowak G, et al. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol. 2006 Nov;149 (5) :581-90.|[2]Olpe HR, et al. The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur J Pharmacol. 1993 Mar 23;233 (2-3) :179-86.|[3]Andrén PE, et al. Blood-brain barrier penetration of 3-aminopropyl-n-butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry. J Mass Spectrom. 1998 Mar;33 (3) :281-7. |[4]Pittaluga A, et al. Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA (B) receptor antagonists. Neuropharmacology. 2001 Sep;41 (3) :301-10.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
Phase 2CAS Number :
[123690-78-8]

